虎黄烧伤搽剂治疗烧伤患者的临床观察
x

请在关注微信后,向客服人员索取文件

篇名: 虎黄烧伤搽剂治疗烧伤患者的临床观察
TITLE:
摘要: 目的:观察虎黄烧伤搽剂治疗烧伤患者的临床疗效及安全性。方法:选取门诊烧伤患者400例,按随机数字表法分为对照组和治疗组,各200例。对照组患者创面清洗后,给予磺胺嘧啶银霜涂于创面,厚度0.15~0.30 mm,每日换药1次;治疗组患者给予虎黄烧伤搽剂每日涂搽创面1~3次。两组均用药至愈合为止。观察两组患者临床疗效、创面愈合时间及细菌感染率,采用视觉模拟(VAS)评分法评价患者疼痛程度,观察两组不良反应发生情况。结果:治疗组患者临床疗效、创面治愈时间及细菌感染率均显著优于对照组,差异有统计学意义(P<0.05)。治疗前,两组患者VAS评分比较,差异无统计学意义 (P>0.05);治疗后,两组患者VAS评分均明显降低,且治疗组明显低于对照组,差异均有统计学意义(P<0.05)。两组患者均未见明显不良反应发生。结论:虎黄烧伤搽剂治疗烧伤疗效显著,能有效促进患者创面愈合,避免创面感染,并有较好的止痛效果,安全可靠。
ABSTRACT: OBJECTIVE: To observe clinical efficacy of Huhuang burn liniment in the treatment of burn. METHODS: 400 patient with burn selected from outpatient department were divided into control group and treatment group according to random number table, with 200 cases in each group. Control group was given Sulfadiazine silver cream with thickness of 0.15-0.30 mm thick, once a day after cleaning the wound. Treatment group was given Huhuang burn liniment, 1-3 times daily until completely healing. Clinical efficacy, healing time of the wound and bacterial infection rate were compared between 2 groups, VAS score was used to evaluate pain degree and the occurrence of ADR was observed. RESULTS: Clinical efficacy, healing time of the wound and infection rate of treatment group were better than those of control group, with statistical significance (P<0.05). There was no statistical significance in VAS score between 2 groups before treatment (P>0.05). After treatment, VAS score of 2 groups were decreased significantly, and the treatment group was significantly lower than the control group, with statistical significance (P<0.05). No obvious ADR was found in 2 groups. CONCLUSIONS: Huhuang burn liniment is effective in the treatment of burn, and can promote wound healing, avoid the infection of the wound and effectively relieve pain with good safety.
期刊: 2016年第27卷第32期
作者: 金梅,张成志
AUTHORS: JIN Mei,ZHANG Chengzhi
关键字: 虎黄烧伤搽剂;磺胺嘧啶银霜;烧伤;临床疗效
KEYWORDS: Huhuang burn liniment; Sulfadiazine silver cream; Burn; Clinical efficacy
阅读数: 416 次
本月下载数: 5 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!